Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 28 of 99

  1. CORT125134 150 mg

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  2. CORT125236

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  3. CORT125281-600

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  4. CORT125329 lipid capsule formulation

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  5. COVID-HIG

    United Therapeutics Europe Ltd

    SARS-CoV-2 Infection

    phase 1 mab completed

    1 trial

  6. COVID-HIGIV

    United Therapeutics Europe Ltd

    COVID-19

    phase 1 mab completed

    1 trial

  7. CP543.1017

    Lacuna Pharma Pty Ltd

    alopecia areata

    phase 1 other active

    1 trial

  8. CPA 556-24

    s.r.o.

    healthy subjects, It is used in conditions with decreased immunity to enhance it e.g. in case of recurrent and chronic viral infections.

    phase 1 other active

    1 trial

  9. CPA 560-24

    Lacuna Pharma Pty Ltd

    influenza

    phase 1 other active

    1 trial

  10. CPDR001X2X01B

    Novartis Pharmaceuticals

    Different types of advanced cancer

    phase 1 small molecule active

    1 trial

  11. CPI-006

    Corvus Pharmaceuticals

    Non-Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  12. CPI-006

    Corvus Pharmaceuticals

    COVID-19

    phase 1 small molecule completed

    1 trial

  13. CPI-444 Capsules

    Corvus Pharmaceuticals

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  14. CPI-818

    Corvus Pharmaceuticals

    T-cell Lymphoma

    phase 1 small molecule active

    1 trial

  15. CPIT565B12101

    Novartis Pharmaceuticals

    Systemic Lupus Erythematosus

    phase 1 other active

    1 trial

  16. CPIT565C12101

    Novartis Pharmaceuticals

    Rheumatoid Arthritis

    phase 1 other active

    1 trial

  17. CPO25001

    Lacuna Pharma Pty Ltd

    No therapeutic indication in the current trial with healthy volunteers.

    phase 1 other active

    1 trial

  18. CPP-115

    CATALYST PHARMACEUTICALS, INC.

    Cocaine Dependency

    phase 1 small molecule completed

    1 trial

  19. CPS-101

    Camp4 Therapeutics Corp

    Urea cycle disorders (UCD)

    phase 1 small molecule active

    1 trial

  20. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Myelodysplastic Syndromes

    phase 1 small molecule active

    2 trials

  21. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Acute Myelogenous Leukemia

    phase 1 small molecule completed

    1 trial

  22. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Malignancy

    phase 1 small molecule completed

    1 trial

  23. CPX-351 (Cytarabine:Daunorubicin) Liposome Injection

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Neoplasms

    phase 1 small molecule completed

    1 trial

  24. CRB-913

    Corbus Pharmaceuticals Holdings

    Obese But Otherwise Healthy Participants

    phase 1 small molecule active

    1 trial

  25. CRB4101

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Adult Subjects

    phase 1 small molecule active

    1 trial

  26. CRC2024_01

    Verona Pharma Ireland Limited

    Patients with low Vitamin D plasma level

    phase 1 other active

    1 trial

  27. CRD-TMH-001

    Ultragenyx UK Limited

    Duchenne Muscular Dystrophy

    phase 1 small molecule active

    1 trial

  28. CRN00808

    Crinetics Pharmaceuticals Europe GmbH

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  29. CRN01941 Oral Solution

    Crinetics Pharmaceuticals Europe GmbH

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  30. CRN04894 Oral Solution

    Crinetics Pharmaceuticals Europe GmbH

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  31. CRV431

    Hepion Pharmaceuticals

    Hepatitis B

    phase 1 small molecule completed

    1 trial

  32. CS-101

    The First People's Hospital of Lianyungang

    Beta-Thalassemia

    phase 1 mab completed

    1 trial

  33. CS-1103

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    phase 1 small molecule completed

    1 trial

  34. CSET N°2021/3339

    The George Institute

    Neoadjuvant therapy in locally-advanced rectal cancer

    phase 1 other active

    1 trial

  35. CSL760

    CSL Behring GmbH

    Coronavirus Disease 2019 (COVID-19)

    phase 1 mab terminated

    1 trial

  36. CSO24001

    Lacuna Pharma Pty Ltd

    No therapeutic indication in the current trial with healthy volunteers.

    phase 1 other active

    1 trial

  37. CT-0508

    Carisma Therapeutics

    HER2-positive

    phase 1 mab active

    1 trial

  38. CT-0525

    Carisma Therapeutics

    HER2-positive

    phase 1 small molecule active

    1 trial

  39. CT-202

    Context Therapeutics

    Triple Negative Breast Cancer (TNBC)

    phase 1 small molecule active

    1 trial

  40. CT-95

    Context Therapeutics

    Mesothelin-Expressing Tumors

    phase 1 small molecule active

    1 trial

  41. CT-996

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    phase 1 small molecule completed

    1 trial

  42. CT-G11

    Celltrion Healthcare Australia Pty Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  43. CT-P41

    Celltrion Healthcare Australia Pty Ltd

    Healthy Male Subjects

    phase 1 mab completed

    1 trial

  44. CT-P51 1.1

    Celltrion Healthcare Australia Pty Ltd

    Completely Resected Stage IIB, IIC, and III Melanoma

    phase 1 other active

    1 trial

  45. CT-P6 SC

    Celltrion Healthcare Australia Pty Ltd

    Healthy

    phase 1 mab completed

    1 trial

  46. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  47. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia (AML)

    phase 1 small molecule terminated

    1 trial

  48. CT1812

    COGNITION THERAPEUTICS INC

    Cognitive Impairment

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.